IJU Case Reports (Nov 2022)

Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome

  • Koshiro Nishimoto,
  • Noriaki Lukas Santo,
  • Masato Yonamine,
  • Kazuhiro Takekoshi,
  • Go Kaneko,
  • Suguru Shirotake,
  • Hisayo Fukushima,
  • Yoshitaka Okada,
  • Masanori Yasuda,
  • Akihiro Sakurai,
  • Masafumi Oyama,
  • Kento Kanao

DOI
https://doi.org/10.1002/iju5.12514
Journal volume & issue
Vol. 5, no. 6
pp. 459 – 463

Abstract

Read online

Introduction Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. Although pheochromocytoma is currently defined as a malignant tumor, MEN2A‐associated pheochromocytoma is known to have a small risk of metastasis. Case presentation The case was a 62‐year‐old Japanese male with bilateral pheochromocytoma, multiple metastases in the liver and bones, and a cardiac thrombus. Genetic testing revealed a pathological variant at codon 634 of the RET gene, thereby leading a diagnosis of MTC. We considered that the multiple metastases were due to MTC; however, a liver biopsy revealed metastasis of pheochromocytoma. Conclusion When pheochromocytoma precedes MTC, the diagnosis of MEN2A may be difficult.

Keywords